Huntington's disease (HD) is a heritable neurodegenerative disorder with heart disease implicated as one major cause of death. While mechanisms responsible are unknown, autonomic nervous system (ANS) dysfunction may play a role. We studied the cardiac phenotype in the R6/1 transgenic HD model at early (3-month-old) and advanced (7-month-old) stages of HD. While R6/1 mice exhibited a modest reduction in cardiomyocyte size, cardiac function was preserved. Conscious ECG telemetry revealed absence of circadian variation of heart rate (HR) and higher HR levels than wild-type littermates in young but not older R6/1 mice. In the latter, plasma noradrenaline was increased and this was associated with reduced cardiac noradrenaline content. R6/1 mice also had unstable R-R intervals that were reversed following atropine treatment, suggesting parasympathetic nervous activation, and developed brady-and tachyarrhythmias, including paroxysmal atrial fibrillation and sudden death. Abbreviations AF, atrial fibrillation; ANS, autonomic nervous system; DAP, diastolic aortic pressure; dP/dt max , maximal rate of rise of LV pressure; dP/dt min , maximal rate of fall of LV pressure; DSI, Data Sciences International; FS, fractional shortening; HD, Huntington's disease; HR, heart rate; HRV, heart rate variability; LV, left ventricle or left ventricular; LVDd, LV dimension at diastole; LVEDP, LV enddiastolic pressure; LVSP, LV systolic pressure; NA, noradrenaline; PVN, paraventricular nucleus of the hypothalamus; poly-Q, poly-glutamine; SAP, systolic aortic pressure; SDNN, standard deviation of normal R-R intervals; WT, wildtype 2
Introduction
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG repeat expansion within the huntingtin gene resulting in an abnormal elongation of the polyglutamine (poly-Q) tract of the huntingtin protein. The pathological consequences include neuronal dysfunction and formation of protein aggregates containing ubiquitinated forms of the mutant protein (Bates, 2005) . HD patients progressively present with symptoms of clinical psychiatric disorders, cognitive deficits, dementia and physical disability (Munoz-Sanjuan & Bates, 2011) . There is no cure or effective treatment for HD and death typically occurs 15-20 years after the onset of HD motor symptoms.
Recent research on the abnormalities of peripheral organs or tissues in HD has extended our understanding of HD pathophysiology and provided clues for the design of new reparative therapies (Sassone et al. 2009; van der Burg et al. 2009 ). While HD is primarily a disease of the central nervous system, early epidemiological reviews of mortality of HD patients indicated pneumonia (about 40%) and heart disease (about 30%) as leading causes of death (Chiu & Alexander, 1982; Lanska et al. 1988; Sorensen & Fenger, 1992) . The nature of cardiac abnormalities in HD patients remains completely unknown. Aberrant activity of the autonomic nervous system (ANS), specifically sympathetic nervous activation together with parasympathetic withdrawal has been reported in HD patients by several groups based on heart rate variability (HRV) as a marker of ANS function (Den Heijer et al. 1988; Sharma et al. 1999; Andrich et al. 2002; Kobal et al. 2004; Bar et al. 2008) . The relation between ANS dysfunction and potential cardiac consequences was not addressed in these studies. R6 mice were the first models of HD that contained the 5'-end of the human HD gene and consequently expressed mutant forms of the protein (Mangiarini et al. 1996; Bates et al. 1997) . Two transgenic lines, R6/1 and R6/2, have been commonly used for HD research (Mangiarini et al. 1996; Bates et al. 1997) . Both transgenic lines develop cognitive deficits followed by motor disorders that closely model HD, as well as progressive dysfunction of the cerebral cortex and striatum, and molecular abnormalities (Mangiarini et al. 1996; Gil & Rego, 2009) . Unlike R6/2 mice that develop motor symptoms around 2 months of age and survive up to 4 months, the R6/1 3 mice develop adult-onset depressive-like abnormalities and cognitive deficits by 3 months and motor symptoms around 4 months of age, and have a life-span of 10 months (Mangiarini et al. 1996; Gil & Rego, 2009; Pang et al. 2009 ). In the current study, we have examined the neurocardiac phenotype in R6/1 mice from 3 to 7 months of age covering early to advanced HD phases.
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Methods
Ethical approval
All experimental procedures were approved by the local Alfred Medical Research and Education Precinct Animal Ethics Committee and were in accordance with the Australian Government National Health and Medical Research Council Code of Practice for the Care and Use of Animals for Scientific Purposes (7 th edition, 2004).
Animals
Male R6/1 mice (CAG repeat length of 134-138) and wildtype (WT) littermates of CBA×C57Bl/6 background were used. Animals were housed together with 3-6 per cage (unless otherwise specified), and maintained on a 12:12-h light-dark cycle with water and food at libitum.
Assessment of cardiac function and histology
Cardiac function was assessed using echocardiography and micromanometry. Mice were maintained under light isoflurane anaesthesia (~1.7%) for non-invasive serial echocardiographic tests at 3, 5 and 7 months of age. LV dimension at diastole (LVDd), fractional shortening (FS) and HR were determined. Mice fully recovered after removal of the anaesthesia at the end of the echocardiographic test.
For micromanometry experiments, mice were anaesthetised with isoflurane (~2-3%). Surgical anaesthesia depth was confirmed with the absence of pedal reflex. Using a 1.4F Millar catheter, systolic and diastolic aortic pressures (SAP, DAP), LV systolic pressure (LVSP), LV end-diastolic pressure (LVEDP) and the maximal rates of rise or fall of LV pressures (dP/dt max or dP/dt min ) were determined.
At the end of the micromanometry experiment, isoflurane was increased to 4% and the depth of anaesthesia was confirmed with the absence of pedal reflex. The chest cavity was cut open and the heart removed. Wet weights of atria and ventricles and body weight were obtained, and the tibial length was measured.
LVs were either frozen for biochemical assays or fixed in 10% formalin in PBS and tissue sections with Masson's trichrome staining were prepared. Diameters of about 40 cardiomyocytes per LV were measured in a blinded fashion, and the average was calculated.
Telemetry ECG
Mice were anaesthetised with isoflurane (~2-3%), and carprofen (5 mg/kg s.c.) was administered for analgesia. Surgical anaesthesia depth was confirmed with the absence of pedal reflex. The body of the ETA-F10 ECG radio telemetry transmitter (Data Sciences International, DSI) was positioned in the abdominal cavity and the 2 biopotential leads were anchored subcutaneously on the lower left of the chest wall and over the right pectoral muscle, respectively (Pretorius et al. 2009 ). Telemetry probes were implanted in both young and older mice (3 and 6 months of age, respectively).
Following a 2-week recovery period, telemetry transmitters were turned on and mice were housed individually with cages placed on a receiver pad (model RPC-1, DSI).
Signals from the receiver were passed through an analogue output adapter (Option R08, DSI) and converted by an analogue-to-digital acquisition card (PC plus, National
Instruments 6024E) using software written in Labview (National Instruments). Gross locomotor activity was determined as described previously (Head et al. 2004) . Data were also converted into European Data Format files which were imported into Chart v5.5.6 (AD Instruments) for analyses.
To assess diurnal patterns, recordings were made continuously for a period of 24 hours while mice were undisturbed. To determine the incidence of different types of arrhythmias, we manually scrolled through 24 hour baseline telemetry ECG recordings.
For each animal, confirmation of the presence and type of arrhythmias was made by 3 persons (XJD, HK, NLJ).
Furthermore, on a separate day to the 24 hour recording, we examined HR response to shake stress during the inactive period (lights-on). As previously described (Davern et al. 2010) , the home cage containing a mouse was placed onto an orbital mixer apparatus set at 100 rpm for 5 min. Recordings were made for a period of 5 min prior to, during and after the shaking, respectively.
In a separate experiment on mice anaesthetised with isoflurane, standard lead-II ECG was recorded and HR changes in response to β-adrenergic and muscarinic antagonists (propranolol 2 mg/kg i.p., atropine 1.2 mg/kg, i.p.) or agonist (isoproterenol 4 μg/kg, i.p.) were determined. Body temperature was monitored using a rectal probe, and maintained at 36-37 ºC using a heat lamp. While anesthesia is commonly associated with alteration of ANS activity, isoflurane anesthesia has less interference relative to 6 other anesthetics on the autonomic activity or baseline HR (Tan et al. 2003) . Corrected QT interval (QT c ) was calculated as: QTc=QT/(R-R/100) 1/2 (Mitchell et al. 1998) .
Biochemical assays
RNA was extracted from the LV and expression of various cardiac genes was determined, along with housekeeping gene (18S), by quantitative real-time RT-PCR as we previously described (Du et al. 2006) . Plasma and cardiac content of NA was determined by HPLC, as previously described (Lambert & Jonsdottir, 1998; Du et al. 1999 ).
Brain immunohistochemistry
Brains were collected 4 h prior to lights-off when animals were in the inactive phase of a 24-h cycle. Mice were anesthetised (mixture of ketamine (100 mg/kg) and xylazine 
Statistics
Results are presented as mean±SEM, unless otherwise specified. Statistical analysis was performed using Student's t-test or ANOVA for repeated measures and Bonferroni posthoc t-test. Fisher Exact test was used to compare in the incidence of arrhythmias.
p<0.05 was considered as statistically significant.
Results
Gross and cardiac phenotypes of R6/1 mice
Male R6/1 mice were studied from 3 to 7 months of age. HD phenotypes were fully developed during this period manifested by a progressive loss in body mass and motor abnormalities (Fig. 1A, B) . Using non-invasive echocardiography and invasive micromanometry, we observed maintained cardiac function in R6/1 mice at both ages, except for a lower blood pressure (Table 1 ). R6/1 mice had a significant and agedependent reduction in heart weight, which was largely in proportion to the reduced body mass (Table 1) . Histologically, there was a modest reduction in cardiomyocyte size of the LV in R6/1 mice at both 3 and 7 months of age ( Fig. 1C, D) . There was no sign of cardiomyocyte disarray, cell death or fibrosis (Fig. 1C ).
In general, LV expression levels were largely unchanged between R6/1 and WT mice for a number of genes including those important for myocardial structure, function and energy metabolism (α-myosin heavy chain, sarcoplasmic reticulum calcium ATPase, β 1 -adrenoceptors, glucose transporter 4, carnitine palmitoyltransferase 1β, peroxisome proliferator activated receptor γ coactivator 1-α and vascular endothelial growth factor), and fetal genes (β-myosin heavy chain, atrial natriuretic peptide) and genes encoding extracellular matrix proteins (procollagen I, procollagen III) ( Table 2 ).
Circadian pattern of heart rate and changes in R-R intervals in conscious mice
The circadian variation of HR was clearly present in WT mice, but was absent in R6/1 mice at both ages studied ( Fig. 2A, B) . HR in 3.5-month-old R6/1 mice was significantly higher than age-matched WT mice ( Fig. 2A) . At 6.5 months of age, HR levels during the active period (lights-off) were lower in R6/1 than WT controls ( Fig.   2B ). R6/1 and WT mice at both ages showed circadian variation in physical activity ( Fig. 2A, B) . However, the telemetry measure of physical activity employed in this study cannot discern a small scale of physical movement.
To further explore phenotype of autonomic nervous activity in R6/1 mice, we analysed beat-to-beat HR variation using ECG from in conscious mice during their inactive period. R6/1 mice exhibited a greater degree of unstable HR compared to WT littermates as shown by chaotic HR rhythm and irregular beat-to-beat R-R intervals 9 ( Fig. 3A-C) . Irregularity of R-R intervals was also evident in R6/1 mice anesthetised with isoflurane (Fig. 4A) . Treatment with atropine (1.2 mg/kg, i.p.) reduced the scattered in R-R intervals, suggesting that the marked beat-to-beat variation seen in R6/1 mice is likely due to an enhanced but variable parasympathetic tone. Elevated cardiac parasympathetic tone in R6/1 compared to WT mice was also indicated by a greater standard deviation of normal R-R intervals (SDNN), which was attenuated after atropine treatment (Fig. 4B) . In WT mice, treatment with atropine did not significantly alter SDNN, indicating that our experimental conditions per se did not increase parasympathetic activity.
We also examined the effect of atropine on HR response to the β-adrenergic agonist isoproterenol in isoflurane-anesthetised mice at 5 months of age. Isoproterenol was tested at 4 μg/kg (i.p.), a dose known to stimulate close to maximal cardiac functional responses. Under isoflurane anesthesia, administration of isoproterenol elicited a marked HR increase in WT but the chronotropic response was blunted in R6/1 mice (Fig. 4C) . Interestingly, pre-treatment with atropine (1.2 mg/kg, i.p. 10 min) completely restored the HR response to isoproterenol (Fig. 4D) . Thus, the effect of atropine in both experiments implies an elevated parasympathetic tone in R6/1 mice. Under the anesthetised conditions, the β-blocker propranolol (1 mg/kg, i.p.) similarly lowered HR in WT and R6/1 mice (-85±21 vs. -103±36 beats/min, respectively; n=8-9, p>0.05,
Student's unpaired t-test).
HR response to stress test
In 3-month-old mice, peak HR response to the shake stress test of 5 min in duration was not significantly different between the genotypes, but R6/1 mice showed a slower restoration of HR back to baseline during the 5-min period (Fig. 5A ). At 7 months of age, the peak HR response to the stress test tended to be blunted in R6/1 compared to that of WT littermates (p=0.07, Fig. 5B) .
Noradrenaline measures
Plasma level of noradrenaline (NA) was similar between R6/1 and WT mouse hearts at 3 months of age but was 5-fold higher in 7-month-old HD versus WT groups (Fig. 6) .
NA content was similar in the LV of R6/1 and WT mice at 3 months of age, but was 40% lower in R6/1 than WT mice at 7 months of age (Fig. 6) , likely due to excessive neuronal release.
Arrhythmia phenotype in R6/1 mice
The ECG parameters at stable basal conditions were comparable between R6/1 and WT mice (Table 1) . However, telemetry ECG recording of conscious R6/1 mice of 3.5 and 6.5 months of age revealed a variety of arrhythmias including atrial-ventricular conduction blockade (mostly occurring as a single episode without consistent change in preceding P-R intervals, Fig. 7A ), sinus arrhythmia (Fig. 7A ), atrial flutter (Fig. 7B ), atrial fibrillation (AF) (Fig. 7C) , supra-ventricular and ventricular premature beats (Fig. 7D, E), and short episodes of ventricular tachycardia (Fig. 7F) . Arrhythmia incidence data from 3.5 and 6.5 month old mice per group were combined. Table 3 summarises the types of arrhythmias detected over a 24 hour period, showing a significantly greater incidence and severity of arrhythmias in R6/1 compared to WT mice. Autopsy showed no signs that indicated heart failure or gross cardiac pathology. R6/1 mice had no change in the weight of atria (Table 1) .
Of 16 R6/1 mice that were under investigation, 3 died at 6-7 months of age. One R6/1 mouse died during conscious ECG telemetry monitoring, and Fig. 8 shows unstable HR, atrial-ventricular dissociation and slow ventricular rhythm prior to death.
Number of activated neurons in relevant brain regions
To explore whether enhanced sympathetic and parasympathetic nervous activities was due to a centrally-mediated mechanism, we determined the number of c-Fos positive neurons in the relevant regions of the brain. Based on the HR circadian variation (Fig. 2), animals were anesthetised 4 h before 'lights-off' when mice normally would be in the inactive phase of a 24-h cycle. By c-Fos immunohistochemistry, we found a 2-fold increase in the number of active neurons in R6/1 than WT brain regions including the PVN, bed nucleus of the stria terminals and central and medial nuclei of the amygdala (Fig. 9A,B) .
Discussion
We aimed to provide experimental insights into cardiac-associated abnormalities in HD.
Our thorough investigation of the R6/1 mice has led to several novel findings. There is evidence for cardiac abnormalities owing to poly-Q aggregates in cardiomyocytes. Pattison et al. (2008) generated transgenic mice with cardiomyocyterestricted expression of polyglutamine encoding transgene leading to cardiac dilatation, hypertrophy (with an upregulated fetal gene profile), fibrosis and heart failure death.
Using the R6/2 model, Mihm et al. (2007) reported LV dilatation and contractile dysfunction by 8 weeks of age. The authors also observed the presence of poly-Q aggregates in R6/2 hearts (Mihm et al. 2007 ). Even at the advanced HD phase, we found that R6/1 mice neither show cardiac histopathology (such as fibrosis, cardiomyocyte apoptosis or hypertrophy) nor dysfunction, albeit a moderate degree of reduction in the heart mass and a lower arterial blood pressure were detected. The cardiac phenotype seen in the R6/1 mice in comparison to that of the R6/2 or poly-Q transgenic mouse models (Mihm et al. 2007; Pattison et al. 2008) , implies that cardiac pathophysiology seen in the latter two models might be due to very high levels of poly-Q aggregates and thus may therefore less closely mimic what occurs in human HD patients.
A moderate extent of cardiac atrophy was observed in R6/1 mice given the reduction in heart weight and cardiomyocyte size. The reason for this phenotype remains unclear. Skeletal striated muscle atrophy is well documented in HD patients and animal models of HD, and has been attributed to disruption of gene expression and cellular function associated with the presence of the mutant huntingtin gene (Sassone et al. 2009; van der Burg et al. 2009 ).
Our study implies significant cardiac ANS dysregulation in the R6/1 mice.
Although plasma and cardiac NA levels were not altered at 3 months of age, a sustained enhancement of sympathetic nervous activity is indicated by higher HR levels together with the loss of circadian pattern in 3-month-old R6/1 mice. Likewise, episodes of sinus tachycardia or tachyarrhythmias are likely the consequence of elevated cardiac sympathetic drive. A long-term sustained cardiac sympathetic activation is strongly indicated by the finding in R6/1 mice at 7 months of age of a marked increase in plasma levels of NA together with a profound reduction in cardiac NA content. These changes are very similar to that seen in the setting of heart failure with sustained sympathetic activation (Liang et al. 1991; Himura et al. 1993; Meredith et al. 1993) . Age-dependent alterations in telemetry HR levels or peak HR response to shake stress test were apparent in 7-versus 3-month-old R6/1 mice, likely due to the development of desensitization of cardiac β-adrenergic signalling following a long-term sympathetic overdrive.
Our findings also suggest activation of the parasympathetic nervous system, as evidenced by atropine reducing the marked variation in R-R intervals, and a blunted HR response to isoproterenol in R6/1 mice. The restoration by atropine pre-treatment of the HR response to isoproterenol in anesthetised R6/1 mice implies tonic post-synaptic inhibition of β-adrenergic responses by the parasympatho-muscarinic signalling under our experimental conditions. Parasympathetic hyperactivity is especially evident in patients with the juvenile or rigid forms of HD (Stober et al. 1983) . Unstable HR with episodes of single atrial-ventricular blockade or sinus bradycardia is likely evoked by an augmented parasympathetic tone.
The loss of the circadian pattern of HR in R6/1 mice is in line with recent reports on abnormalities in circadian physiological cycle in HD models including R6/2 mice (Morton et al. 2005; Kudo et al. 2011) . Interestingly, in the present study although the circadian pattern of HR was lost, the circadian cycle in physical activity in R6/1 mice remained intact. Our experimental protocol cannot exclude the possibility that mice were periodically waking up during the inactive period but were not moving around the 13 cage (and therefore not registered on the telemetry activity channel). In fact, using video technology to monitor R6/2 mice in their home cage, Steele et al. (2007) revealed that, compared to WT mice, the HD mice displayed 2.5 fold increased awakening events, increased twitching (during rest) and hypergrooming, but decreased distance travelled and activities such as stretching, hanging vertically and jumping. Studies on HD patients also have shown nocturnal sleep disturbances together with daytime somnolence (Morton et al. 2005; Aziz et al. 2009; Videnovic et al. 2009; Aziz et al. 2010) .
Clinical studies have consistently reported sympathetic predominance and parasympathetic withdrawal in HD patients relative to healthy controls (Den Heijer et al. 1988; Sharma et al. 1999; Andrich et al. 2002; Kobal et al. 2004; Bar et al. 2008) . In these studies, ANS activity was assessed using the HRV technique. However, these studies might suffer from some limitations. The source of raw data was from a very brief period (1 to 10 min) of ECG recording in patients known to have an unstable psychological state. There was lack of confirmative validation or specificity, and it was difficult to ascertain the onset or timing of ANS dysfunction along the course of HD.
Importantly, these studies did not relate ANS abnormalities to cardiac consequences and excluded patients with arrhythmias (Andrich et al. 2002; Kobal et al. 2004; Bar et al. 2008 ). Thus, further clinical research is required and methods such as 24h-Holter monitoring of ECG should be adopted.
c-Fos expression as a marker of activated neurons has been shown to be increased 40-60 min after a stressor (Dampney et al. 1995; Davern & Head, 2007; Davern et al. 2009 ). Our protocol of brain preparation excluded the influence of acute stressassociated changes on neuronal activity, but revealed "constitutive" activity of brain neurons at the time when animals are normally asleep. A 2-fold increase in the number of active neurons was noticed in various regions of R6/1 brains. These regions are well known in integrating cardiovascular responses to acute stress or anxiety and in governing ANS regulation of the cardiovascular system (Davern & Head, 2007; Davern et al. 2010) . Thus, the ANS dysregulation of the heart is due most likely to abnormalities in the function of brain centres that govern ANS activity.
Early mortality surveys indicated that heart disease constituted the second major cause of death for HD patients (Chiu & Alexander, 1982; Lanska et al. 1988; Sorensen & Fenger, 1992) . The nature of cardiac pathophysiology associated with HD remains 14 largely unknown. An arrhythmogenic role of the activated sympatho-β-adrenergic system has been established in settings of heart diseases such as ischemia or chronic myocardial infarction (Schwartz et al. 1992; Du et al. 1999; Chen & Tan, 2007; Tan et al. 2008) , or in transgenic interventions leading to an enhanced cardiac β-adrenergic activity (Engelhardt et al. 1999; Du et al. 2000) . Here we found that in R6/1 mice, while cardiac function was largely preserved, unstable baseline HR and arrhythmias do occur.
Of interest is our finding of various types of arrhythmias which were short-lasting in nature, in the R6/1 mice free of overt cardiac pathology. AF reported in various mouse models is typically paroxysmal and usually associated with cardiac pathology as arrhythmic substrates (Sah et al. 1999; Xiao et al. 2004; Saba et al. 2005; Pretorius et al. 2009 ). There is evidence that on the background of an enhanced sympathetic nervous activity, parasympathetic activation would enhance the chance of supra-ventricular arrhythmias (Tan et al. 2008) . Further, enhanced sympathetic as well as parasympathetic tone has been shown to induce paroxysmal AF, such as in patients with obstructive sleep-disorder (Leung, 2009 ). Dennervation of cardiac parasympathetic nerves by catheter ablation is also effective in preventing vagal activation-induced AF both experimentally and clinically (Schauerte et al. 2000; Arora et al. 2008 ).
In conclusion, our findings in the R6/1 mice rule out the development of heart failure even at an advanced phase of HD, but suggest a centrally mediated dysregulation by the ANS of cardiac activity with resultant absence of circadian pattern of HR and neurogenic arrhythmias leading to sudden cardiac death. Our findings provide invaluable clues for the design of further clinical investigations, for instance, 24-hour ECG monitoring using Holter system for detecting arrhythmias, more comprehensive HRV analysis or therapeutic testing of neurocardiac symptoms of HD patients and studies on related neurodegenerative diseases. months of age show a clear circadian rhythm in WT (n=4-6/group, effect of time p<0.05) but not in R6/1 mice (n=5-6/group). However, circadian rhythm in physical activity was evident in both genotypes. HR levels over the 24-h period were significantly higher in the 3.5-month-old R6/1 than age-matched WT mice (p=0.002), but not in the older mice (p=0.082). Notably, HR was lower in old compared to young R6/1 mice (p=0.001). Activity was not significantly different between the groups at both ages (p=0.591 and 0.154, respectively). Shaded areas represent lights-off periods of the day. mean±SEM. *p<0.05 vs. WT at specific time-points. Data were analysed using ANOVA for repeated measures and Bonferroni post-hoc t-test. Group data shown in Table 3 . 
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